PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
NIO vs. XBI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

NIO vs. XBI

Last updated Jun 5, 2026

NIO (NIO Inc.) is a stock, while XBI (SPDR S&P Biotech ETF) is Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Over the past 5 years, NIO returned -32.93%/yr vs 1.14%/yr for XBI. At a 0.38 correlation, their price movements are largely independent.

Performance

NIO vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NIO Inc. (NIO) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NIO achieves a 11.57% return, which is significantly higher than XBI's 9.42% return.

NIO

1D
-1.04%
1M
-3.56%
YTD
11.57%
6M
13.57%
1Y
51.73%
3Y*
-9.47%
5Y*
-32.93%
10Y*
—

XBI

1D
2.77%
1M
-0.28%
YTD
9.42%
6M
8.61%
1Y
62.35%
3Y*
15.65%
5Y*
1.14%
10Y*
8.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NIO vs. XBI - Yearly Performance Comparison

2026 (YTD)20252024202320222021202020192018
NIO
NIO Inc.		11.57%16.97%-51.93%-6.97%-69.22%-35.00%1,112.44%-36.89%-3.48%
XBI
SPDR S&P Biotech ETF		9.42%35.89%1.01%7.60%-25.87%-20.45%48.33%32.56%-25.37%

Correlation

The correlation between NIO and XBI is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.40

Correlation (All Time)
Calculated using the full available price history since Sep 13, 2018

0.38

The correlation between NIO and XBI shifts across timeframes, from 0.19 (1 year) to 0.40 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

NIO Inc.

SPDR S&P Biotech ETF

Often compared with NIO:
NIO vs. TSLANIO vs. XPEVNIO vs. LINIO vs. BYDDFNIO vs. RIVNNIO vs. LCIDNIO vs. BABA
Often compared with XBI:
XBI vs. IBBXBI vs. ARKGXBI vs. LABUXBI vs. BBHXBI vs. VOOXBI vs. IBBQXBI vs. FBIOX

Return for Risk

NIO vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
NIO
NIO Risk / Return Rank: 6565
Overall Rank
NIO Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
NIO Sortino Ratio Rank: 6767
Sortino Ratio Rank
NIO Omega Ratio Rank: 6262
Omega Ratio Rank
NIO Calmar Ratio Rank: 6565
Calmar Ratio Rank
NIO Martin Ratio Rank: 6262
Martin Ratio Rank
XBI
XBI Risk / Return Rank: 8080
Overall Rank
XBI Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 7575
Sortino Ratio Rank
XBI Omega Ratio Rank: 6767
Omega Ratio Rank
XBI Calmar Ratio Rank: 9393
Calmar Ratio Rank
XBI Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NIO vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NIO Inc. (NIO) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

NIOXBIDifference
Sharpe ratioReturn per unit of total volatility
0.83
2.45

-1.62

Sortino ratioReturn per unit of downside risk
1.58
3.32

-1.74

Omega ratioGain probability vs. loss probability

1.18

1.40

-0.22

Calmar ratioReturn relative to maximum drawdown

1.19

6.45

-5.26

Martin ratioReturn relative to average drawdown

2.13

19.53

-17.40

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NIO vs. XBI - Sharpe Ratio Comparison

The current NIO Sharpe Ratio is 0.83, which is lower than the XBI Sharpe Ratio of 2.45. The chart below compares the historical Sharpe Ratios of NIO and XBI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

NIOXBIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.83

2.45

-1.62

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.46

0.04

-0.50

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

—

0.27

—

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.02

0.36

-0.39

Drawdowns

NIO vs. XBI - Drawdown Comparison

The maximum NIO drawdown since its inception was -95.00%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for NIO and XBI.

Loading charts...

Drawdown Indicators

NIOXBIDifference

Max Drawdown

Largest peak-to-trough decline

-95.00%

-63.89%

-31.11%

Max Drawdown (1Y)

Largest decline over 1 year

-43.73%

-9.72%

-34.01%

Max Drawdown (3Y)

Largest decline over 3 years

-79.69%

-32.99%

-46.70%

Max Drawdown (5Y)

Largest decline over 5 years

-94.10%

-54.71%

-39.39%

Max Drawdown (10Y)

Largest decline over 10 years

—

-63.89%

—

Current Drawdown

Current decline from peak

-90.95%

-22.89%

-68.06%

Average Drawdown

Average peak-to-trough decline

-67.86%

-20.93%

-46.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.31%

3.20%

+21.11%

Volatility

NIO vs. XBI - Volatility Comparison

NIO Inc. (NIO) has a higher volatility of 18.68% compared to SPDR S&P Biotech ETF (XBI) at 9.69%. This indicates that NIO's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

NIOXBIDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.68%

9.69%

+8.99%

Volatility (6M)

Calculated over the trailing 6-month period

41.00%

20.31%

+20.69%

Volatility (1Y)

Calculated over the trailing 1-year period

62.99%

25.60%

+37.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

71.67%

32.20%

+39.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.70%

32.00%

+54.70%

Dividends

NIO vs. XBI - Dividend Comparison

NIO has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.33%.

PositionTTM20252024202320222021202020192018201720162015
NIO
NIO Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF		0.33%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%

Frequently Asked Questions

NIO and XBI have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NIO has higher volatility (18.68%) compared to XBI (9.69%). In terms of maximum drawdown, NIO dropped -95.00% vs XBI's -63.89%.

XBI currently has the higher Sharpe Ratio (2.45 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NIO and XBI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer